Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of HJ787 ointment in neurodermatitis
CTR20242526Phase 2Active
- Sponsor
- Huajian Future
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HJ787 in neurodermatitis, sponsored by Huajian Future. Started Jul 2024; status: active.
02
Drugs
HJ787
03
Conditions
neurodermatitis
Beyond the preview
Go deeper on CTR20242526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242526.